Health Catalyst will present at several upcoming investor conferences in November and December 2025.
Quiver AI Summary
Health Catalyst, Inc., a prominent provider of data and analytics technology for healthcare organizations, has announced that its senior management team will participate in several upcoming investor conferences. Notable engagements include a fireside chat at The Stephens Annual Investment Conference on November 19 in Nashville, and 1x1 meetings at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 20 in New York. Additionally, they will have a fireside chat at the Evercore Healthcare Conference on December 2 in Miami, followed by 1x1 meeting opportunities at Citi’s Global Healthcare Conference the next day. Health Catalyst supports over 1,100 organizations worldwide with its cloud-based technology and analytics solutions, aiming to improve clinical, financial, and operational outcomes in healthcare.
Potential Positives
- Health Catalyst's participation in multiple prestigious investor conferences demonstrates its proactive approach to engaging with stakeholders and increasing visibility in the market.
- The inclusion of senior management in discussions at these events highlights the company's leadership and expertise, which may build investor confidence and interest.
- The press release emphasizes Health Catalyst's strong market position as a leading provider of data and analytics technology, showcasing its substantial impact on healthcare improvement for over 1,100 organizations worldwide.
Potential Negatives
- Management's participation in multiple investor conferences may indicate a need for increased investor engagement, potentially suggesting previous communication shortcomings.
- The emphasis on 1x1 meetings may imply that the company is actively seeking to address investor concerns or questions, which could indicate prior dissatisfaction among investors.
- The involvement of senior management in multiple events in quick succession could reflect an urgency to clarify the company's strategic direction amidst heightened competition in the data and analytics space.
FAQ
What investor conferences is Health Catalyst attending in November 2025?
Health Catalyst will participate in The Stephens Annual Investment Conference and the Canaccord Genuity MedTech Forum in November 2025.
Who are the key speakers at the Health Catalyst events?
Key speakers include Dan Burton, Ben Albert, Jason Alger, and Matt Hopper at the upcoming conferences.
When is the Stephens Annual Investment Conference?
The Stephens Annual Investment Conference is scheduled for November 19, 2025, at 3:00 PM CT.
What is Health Catalyst's core offering?
Health Catalyst provides data and analytics technology and services aimed at improving healthcare outcomes and operational efficiency.
How can I contact Health Catalyst for media or investor inquiries?
For media inquiries, contact Kathryn Mykleseth at [email protected]; for investor relations, email Matt Hopper at [email protected].
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$HCAT Insider Trading Activity
$HCAT insiders have traded $HCAT stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $HCAT stock by insiders over the last 6 months:
- BENJAMIN LANDRY (General Counsel) has made 0 purchases and 2 sales selling 12,232 shares for an estimated $44,595.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HCAT Hedge Fund Activity
We have seen 65 institutional investors add shares of $HCAT stock to their portfolio, and 102 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 2,085,392 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $7,861,927
- WHETSTONE CAPITAL ADVISORS, LLC added 2,026,278 shares (+118.8%) to their portfolio in Q2 2025, for an estimated $7,639,068
- PORTOLAN CAPITAL MANAGEMENT, LLC removed 1,980,409 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $5,644,165
- FIRST LIGHT ASSET MANAGEMENT, LLC added 1,793,374 shares (+17.2%) to their portfolio in Q2 2025, for an estimated $6,761,019
- PRIMECAP MANAGEMENT CO/CA/ removed 617,620 shares (-31.1%) from their portfolio in Q3 2025, for an estimated $1,760,217
- BAIRD FINANCIAL GROUP, INC. added 617,183 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,758,971
- SCHRODER INVESTMENT MANAGEMENT GROUP removed 468,692 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,335,772
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$HCAT Analyst Ratings
Wall Street analysts have issued reports on $HCAT in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keybanc issued a "Overweight" rating on 10/08/2025
- Canaccord Genuity issued a "Buy" rating on 08/29/2025
- Wells Fargo issued a "Overweight" rating on 08/11/2025
To track analyst ratings and price targets for $HCAT, check out Quiver Quantitative's $HCAT forecast page.
$HCAT Price Targets
Multiple analysts have issued price targets for $HCAT recently. We have seen 8 analysts offer price targets for $HCAT in the last 6 months, with a median target of $4.0.
Here are some recent targets:
- Daniel Grosslight from Citigroup set a target price of $3.25 on 11/11/2025
- Stan Berenshteyn from Wells Fargo set a target price of $5.0 on 11/11/2025
- David Grossman from Stifel set a target price of $3.75 on 11/11/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $3.0 on 10/08/2025
- Scott Schoenhaus from Keybanc set a target price of $4.0 on 10/08/2025
- Sarah James from Cantor Fitzgerald set a target price of $4.0 on 10/07/2025
- Richard Close from Canaccord Genuity set a target price of $5.0 on 08/29/2025
Full Release
SALT LAKE CITY, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences:
- The Stephens Annual Investment Conference, being held in Nashville, including a fireside chat with Ben Albert, President and Chief Operating Officer, Jason Alger, Chief Financial Officer, and Matt Hopper, SVP of Finance and Head of Investor Relations, on Wednesday, November 19, 2025 at 3:00pm CT.
- The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum, being held in New York, including 1x1 meeting opportunities with Dan Burton, Chief Executive Officer, Ben Albert, President and Chief Operating Officer, Jason Alger, Chief Financial Officer, and Matt Hopper, SVP of Finance and Head of Investor Relations, on Thursday, November 20, 2025.
- The 8th Annual Evercore Healthcare Conference, being held in Miami, including a fireside chat with Dan Burton, Chief Executive Officer, Ben Albert, President and Chief Operating Officer, Jason Alger, Chief Financial Officer, and Matt Hopper, SVP of Finance and Head of Investor Relations, on Tuesday, December 2, 2025 at 8:20am ET.
-
The Citi’s 2025 Global Healthcare Conference, being held in Miami, including 1x1 meeting opportunities with Dan Burton, Chief Executive Officer, Ben Albert, President and Chief Operating Officer, Jason Alger, Chief Financial Officer, and Matt Hopper, SVP of Finance and Head of Investor Relations, on Wednesday, December 3, 2025.
About Health Catalyst
Health Catalyst (Nasdaq: HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,100 organizations worldwide rely on Health Catalyst's offerings, including our cloud-based technology ecosystem Health Catalyst Ignite™, AI-enabled data and analytics solutions, and expert services to drive meaningful outcomes across hundreds of millions of patient records. Powered by high-value data, standardized measures and registries, and deep healthcare domain expertise, Ignite helps organizations transform complex information into actionable insights. Backed by a multi-decade mission and a proven track record of delivering billions of dollars in measurable results, Health Catalyst continues to serve as the catalyst for massive, measurable, data-informed healthcare improvement and innovation.
Media Contact:
Kathryn Mykleseth
Director of PR and Communications
[email protected]
Investor Relations Contact:
Matt Hopper
SVP of Finance and Head of Investor Relations
[email protected]
